TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$61.21
-2.75 (-4.30%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+33.2% upside
Low Target
$66.63
Average Target
$81.52
High Target
$107.19
Current Price
$61.21
Current
$61.21
$61.21
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Scenario Analysis
Bear Case
$66.63
8.9%
Low target
Base Case
$81.52
+33.2%
Avg target
Bull Case
$107.19
+75.1%
High target
Risk/Reward
8.5x
Highly favorable
Price in Context
52-Week High
$85.25
-28.2% from high
52-Week Low
$38.51
+58.9% from low
50-Day SMA
$73.37
-16.6% vs SMA
200-Day SMA
$59.46
+2.9% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$81.52
-4.4% vs high
Next Earnings Report
May 12, 2026
2d
until earnings
EPS Est: $-0.32
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals